TCL Archive SPOREs hammer out research agenda, seek $50,000 from NCI for further tissue analysis. April 30, 2004
TCL Archive In Brief: Georgetown Professor Heads Cancer Therapy Evaluation Program; NCI-VA Branch Abolished September 7, 1979
TCL Archive In Brief: Gramm-Rudman-Hollings Could Slash NCI Budget By $650 Million; Holleb Retires From ‘Ca’ July 27, 1990
TCL Archive FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview. November 7, 2003
